Affinity Asset Advisors LLC 13D/13G Filings for Sutro Biopharma, Inc. (STRO)

Affinity Asset Advisors LLC 13D and 13G filings for Sutro Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-01-29
7:58 pm
Purchase
2026-01-2213GSutro Biopharma, Inc.
STRO
Affinity Asset Advisors LLC748,382
8.800%
748,382increase
(New Position)
Filing